The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts. 

Related News Articles

Headline
The Cybersecurity and Infrastructure Security Agency, Federal Bureau of Investigation, Multi-State Information Sharing and Analysis Center and international…
Headline
The FBI and Cybersecurity and Infrastructure Security Agency Nov. 16 recommended health care and other critical infrastructure take steps to protect their…
Headline
The FBI, Cybersecurity and Infrastructure Security Agency, and Multi-State Information Sharing and Analysis Center Nov. 15 issued a warning about Rhysida…
Headline
The FBI and Cybersecurity and Infrastructure Security Agency today released an update on Royal ransomware and encouraged health care and other critical…
Headline
The Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center (HC3) this week alerted the sector to a new ransomware threat…
Headline
The Food and Drug Administration has recognized a consensus standard to help medical device makers address cybersecurity concerns. The agency said the SW96:…